Synonym: Long R3 Insulin-Like Growth Factor-I
Species: Human
Protein Accession: P05019
Purity: >95%
Endotoxin Level:
<1.0 EU/μg
Biological Activity: The ED50 as determined by a cell proliferation assay
using FDC-P1 cells is less than 0.1 ng/mL
Expression System: E. coli
Fusion Tag: His Tag
Predicted Molecular Mass: 8.5 kDa
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS
Reconstitution: We recommend that this vial be briefly centrifuged prior
to opening to bring the contents to the bottom. Reconstitute in sterile
distilled water or aqueous buffer containing 0.1% BSA to a concentration of
0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and
stored at ≤ -20°C.
Storage & Stability: The lyophilized powder should be stored desiccated at
-20°C. Although it has been tested stable at room temperature for 3 weeks, it is
best stored desiccated below -20°C. Upon reconstitution, store at 4°C between
2-7 days and for future use below -20°C. For long-term storage it is recommended
to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
FAQ
How does Y03101 Recombinant Human LR3 IGF1 benefit animal growth and
development?
Y03101 Recombinant Human LR3 IGF1 (Insulin-like Growth
Factor 1) is designed to stimulate and enhance growth in livestock by mimicking
the effects of naturally occurring IGF1 in the body. IGF1 is a crucial hormone
involved in growth and development, and this recombinant form, LR3 IGF1, has
been engineered to be more potent and longer-lasting. In feed applications, it
can lead to increased lean muscle mass, improved feed conversion ratios, and
overall enhanced growth rates. This means that animals can reach market weight
more quickly and efficiently. Additionally, Y03101 has been shown to support
immune function and improve overall health, reducing the likelihood of disease
and the reliance on medical treatments.
Are there any known side effects
or risks associated with using Y03101 Recombinant Human LR3 IGF1 in animal
feed?
When used appropriately and according to guidelines, Y03101
Recombinant Human LR3 IGF1 is generally considered safe for use in animal feed.
However, it's important to note that improper dosages or misuse could
potentially lead to adverse effects. Possible side effects might include
hypoglycemia (low blood sugar), overgrowth of certain tissues, or metabolic
imbalances. Long-term use without proper monitoring could also potentially lead
to issues such as insulin resistance. As with any feed additive, it’s crucial to
monitor the animals for any signs of adverse effects and to consult with a
veterinarian or animal nutritionist to ensure proper use.
How is Y03101
Recombinant Human LR3 IGF1 administered in animal feed?
Y03101
Recombinant Human LR3 IGF1 is typically incorporated into animal feed during the
manufacturing process. The dosage and method of incorporation can vary depending
on the species of animal, their age, weight, and specific growth needs. It can
be mixed directly with the feed or premixed with a smaller quantity before being
distributed throughout the entire ration. It’s important to follow the
supplier’s recommendations for dosage and administration to ensure effectiveness
and safety. Additionally, uniform distribution in the feed is essential to
ensure that all animals receive the intended dose, promoting consistent growth
and health benefits.
What species of animals can benefit from Y03101
Recombinant Human LR3 IGF1?
Y03101 Recombinant Human LR3 IGF1 can be
beneficial for a variety of livestock species, including but not limited to
cattle, swine, poultry, and aquaculture species. Each species might respond
differently due to variations in metabolism, growth patterns, and feed habits.
For instance, in cattle and swine, Y03101 can significantly improve lean muscle
mass and feed efficiency, leading to faster growth rates and better meat
quality. In poultry, it can optimize body weight gain and improve feed
conversion ratios. For aquaculture species like fish and shrimp, Y03101 can
enhance growth rates and overall health, which is particularly valuable given
the high-density farming environments these species are often raised in. It's
important to tailor its use to the specific needs and conditions of each species
for the best outcomes.
Is the use of Y03101 Recombinant Human LR3 IGF1 in
animal feed regulated?
Yes, the use of Y03101 Recombinant Human LR3 IGF1
in animal feed is subject to regulatory oversight to ensure its safety and
efficacy. Different countries and regions have specific regulatory bodies, such
as the FDA in the United States or EFSA in the European Union, that set
guidelines for the use of such bioactive compounds in animal feed. These
regulations typically cover aspects such as allowed dosages, administration
methods, and requirements for safety testing. Compliance with these regulations
is mandatory to ensure that the additive is safe for animals, does not lead to
harmful residues in animal products, and does not pose risks to human consumers.
It’s essential for manufacturers and feed producers to stay updated on
regulatory changes and ensure that their use of Y03101 meets all local and
international standards.